MedPath

A study to compare the effectiveness and safety of an oral low dose and megadose of cholecalciferol treatment in participants with vitamin D deficiency - a real-life comparison pilot study.

Phase 4
Recruiting
Conditions
Vitamin D deficiency
Diet and Nutrition - Other diet and nutrition disorders
Registration Number
ACTRN12607000338460
Lead Sponsor
Prof. Peter Ebeling
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Serum 25(0H) concentration < 50 nmol/L and ability to consent to trial participation.

Exclusion Criteria

Inability to either give informed consent or complete the three month study, primary or tertiary hyperparathyroidism or other causes of hypercalcaemia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ormalisation of serum 25(0H) concentrations to > 50 nmol/L[At 3 months]
Secondary Outcome Measures
NameTimeMethod
Safety parameters - serum and urine calcium concentrations.[Serum calcium concentrations will be measured at 10 days and 3 months. 24-hour urine calcium concentrations will be measured at 3 months.]
© Copyright 2025. All Rights Reserved by MedPath